European Journal of Cancer and Clinical Oncology
 1987
DOI: 10.1016/0277-5379(87)90049-6
|Get access via publisher |Summarize |Cite
|
Sign up to set email alerts

A phase I clinical evaluation of 1-(2-chloroethyl)-3-[2-(dimethylaminosulphonyl)ethyl]-1-nitrosourea (TCNU)

Jette Vibe-Petersen1,
E Bork2,
Henrik Møller3
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
19
1
0
0

Citation Types

0
1
0
0

Year Published

1987
1987
2009
2009

Publication Types

Select...
17
3

Relationship

0
20

Authors

Journals

citations

Cited by 20 publications

(1 citation statement)
references

References 5 publications

0
1
0
0
Order By: Relevance
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…This transplantable model has been characterized as an alveologenic-bronchiolar carcinoma and it has been reported as poorly sensitive to BCNU [5]. A lung tumor was chosen since objective responses have been observed in lung cancers in two Phase 1 clinical trials [6,7],…”
Section: Introduction
mentioning
confidence: 99%
Get access via publisher